Rhonda Farnum
SVP, COMM & MEDICAL AFFAIRS · 5 filings · Latest: Jun 15, 2026
Theravance Biopharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TBPH | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Jun 15, 2026 | Sale | $16.39 | 13,314 | $218.2K | 232,457 | |
TBPH | RHONDA FARNUM | — | Jun 15, 2026 | Proposed Sale | $16.39 | 13,314 | $218.2K | — | |
TBPH | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Mar 16, 2026 | Sale | $13.96 | 31,067 | $433.6K | 232,699 | |
TBPH | RHONDA FARNUM | — | Mar 16, 2026 | Proposed Sale | $13.96 | 31,067 | $433.6K | — | |
TBPH | RHONDA FARNUM | — | Dec 3, 2025 | Proposed Sale | $18.75 | 31,067 | $582.5K | — | |
TBPH | RHONDA FARNUM | — | Jul 14, 2025 | Proposed Sale | $11.39 | 10,000 | $113.9K | — | |
TBPH | RHONDA FARNUM | — | Jun 2, 2025 | Proposed Sale | $11.00 | 24,000 | $264.0K | — | |
TBPH | RHONDA FARNUM | — | Jan 21, 2025 | Proposed Sale | $9.00 | 4,000 | $36.0K | — |